EUVIMEDEUVIMED entdecken
Crossref

Logic‐Responsive Superspherical Nucleic Acid Enables Tumor‐Specific Multiplexed Gene Silencing for Efficient Cancer Therapy

Xian‐Ming Guo, Mei‐Ling Zhao, Xia Yang, Xia Zhong, Yan‐Mei Lei, Ying Zhuo

Angewandte Chemie · 21.09.2026 · 138 (39)

DOI: 10.1002/ange.7096315 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie, online erschienen am 21.07.2026. Verfasst von Xian‐Ming Guo und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gene‐targeted therapies are of considerable interest for targeting multiple “undruggable” oncogenes. However, their therapeutic efficacy is largely hampered by off‐target toxicity and inherent tumor heterogeneity. Herein, we describe a logic‐responsive s uper s pherical n ucleic a cid (SSNA) with on‐demand, activatable functionality that enables tumor‐specific multiplexed gene silencing for efficient cancer therapy. The SSNA architecture features a nuclease‐resistant spherical nucleic acid core densely coated with a Y‐shaped DNA circuit shell that selectively responds to apurinic/apyrimidinic endonuclease 1 (APE1), a biomarker overexpressed in tumor cytoplasm. Upon intracellular APE1‐triggered shell disassembly, the SSNA enables the controlled release of split antisense oligonucleotides targeting thymidine kinase 1 ( TK1 ) mRNA and DNAzymes that cleave survivin mRNA. Both in vitro and in vivo results demonstrated robust dual‐gene silencing of TK1 and survivin at both transcriptional and translational levels, accompanied by exceptional tumor specificity and minimal off‐target effects. Notably, in a murine MCF‐7 xenograft model, SSNA significantly suppressed tumor growth and extended median survival by an impressive 70% compared to single‐target interventions. By integrating tumor‐specific activation with multiplexed gene silencing, such an SSNA platform offers a powerful and versatile approach for advancing next‐generation precision cancer therapies.

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Guo, X., Zhao, M., Yang, X., Zhong, X., Lei, Y., & Zhuo, Y. (2026). Logic‐Responsive Superspherical Nucleic Acid Enables Tumor‐Specific Multiplexed Gene Silencing for Efficient Cancer Therapy. Angewandte Chemie, 138(39). https://doi.org/10.1002/ange.7096315

Vancouver

Guo X, Zhao M, Yang X, Zhong X, Lei Y, Zhuo Y. Logic‐Responsive Superspherical Nucleic Acid Enables Tumor‐Specific Multiplexed Gene Silencing for Efficient Cancer Therapy. Angewandte Chemie. 2026;138(39). doi:10.1002/ange.7096315

BibTeX
@article{Guo2026,
  author = {Guo, Xian‐Ming and Zhao, Mei‐Ling and Yang, Xia and Zhong, Xia and Lei, Yan‐Mei and Zhuo, Ying},
  title = {Logic‐Responsive Superspherical Nucleic Acid Enables Tumor‐Specific Multiplexed Gene Silencing for Efficient Cancer Therapy},
  journal = {Angewandte Chemie},
  year = {2026},
  volume = {138},
  number = {39},
  doi = {10.1002/ange.7096315}
}
Kostenlos starten →